Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cequa in Dry Eye Disease Inadequately Controlled by Cyclosporine 0.05%
NCT04357795Phase 4Completed
- Sponsor
- Sun Pharma
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine ophthalmic solution in dry eye disease (DED), sponsored by Sun Pharma. Started Jun 2020; status: completed.
02
Drugs
cyclosporine ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04357795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357795.